Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice

Xue-Mei Zhang,Fang Du,Dan Yang,Rui Wang,Chun-Jiang Yu,Xiang-Nan Huang,Hong-Yan Hu,Wei Liu,Jin Fu

DOI: https://doi.org/10.1186/1471-2202-12-61

2011-06-24

BMC Neuroscience

Abstract:Abstract Background Bone marrow mononuclear cell (BMMC) transplantation is a promising therapy for cerebral ischemia; however, little is known if its therapeutic efficacy may be improved by co-administration of potential modulatory factors in vivo. To explore this possibility, the present study examined the effect of BMMCs and G-CSF on cell proliferation, early neuronal development and neurological function recovery in experimental cerebral ischemia relative to controls that received neither treatment. Result Ischemia/infarct area was significantly reduced in BMMCs+G-CSF group relative to animal groups treated with BMMCs only, G-CSF only or saline. Transplanted BMMCs were found to colocalize with the proliferative cell nuclear antigen (PCNA) and the immature neuronal marker doublecortin (DCX). The BMMCs+G-CSF group showed increased numerical density of cells expressing PCNA and DCX, improved performance in adhesive sticker removal test and reduced neurological function severity scores relative to other groups in a time-dependent manner. Conclusion BMMCs and G-CSF co-administration exhibits synergistic beneficial effect over time. This effect could be at least partially related to increased proliferation and differentiation of bone marrow stem cells and enhanced host brain regeneration and functional recovery. The results suggest that G-CSF can increase the therapeutic efficacy of BMMCs transplantation in an experimental mouse model of cerebral ischemia.

neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether the combined application of granulocyte - colony stimulating factor (G - CSF) and bone marrow mononuclear cells (BMMCs) can enhance the effect of BMMCs transplantation in the treatment of cerebral ischemia in mice. Specifically, the study aims to evaluate the influence of the combined use of G - CSF and BMMCs on cell proliferation, early neuronal development and neurological function recovery, and whether this combined treatment can reduce the infarct area and improve the neurological function recovery in the mouse model of experimental cerebral ischemia. Through this study, the author hopes to explore whether G - CSF can be used as a potential regulatory factor in combination with BMMCs to improve the treatment effect.